Akebia Therapeutics | AKBA - Current Liabilities


Akebia Therapeutics reported $160.86M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 361.44M 55.91M Jun/2026
Agios Pharmaceuticals USD 70.22M 11.37M Jun/2026
Akebia Therapeutics USD 160.86M 13.02M Jun/2026
Alnylam Pharmaceuticals USD 1.51B 163.04M Jun/2026
Amgen USD 25.5B 547M Jun/2026
Ardelyx USD 109.57M 20.96M Mar/2026
Astellas Pharma JPY 1.23T 16.36B Jun/2026
AstraZeneca USD 31.55B 1.02B Jun/2026
Bayer EUR 32.27B 1.19B Jun/2026
BioMarin Pharmaceutical USD 1.66B 870.84M Jun/2026
Celltrion KRW 288.01B 4.7B Jun/2026
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 34.39M 3.89M Jun/2026
Exelixis USD 361.93M 9.05M Jun/2026
Fresenius Medical Care EUR 7.18B 448.03M Jun/2026
GlaxoSmithKline GBP 21.53B 895M Jun/2026
Ionis Pharmaceuticals USD 315.64M 401.36M Jun/2026
Ironwood Pharmaceuticals USD 236.31M 5.91M Mar/2026
J&J USD 55.46B 562M Sep/2026
Kangmei Pharma CNY 5.1B 280.48M Jun/2026
Karyopharm Therapeutics USD 117.3M 25.24M Mar/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Lexicon Pharmaceuticals USD 9.9M 10.97M Mar/2026
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Moderna USD 2.53B 139M Jun/2026
Nektar Therapeutics USD 57.71M 4.17M Mar/2026
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Organigram Holdings CAD 88.74M 5.31M Mar/2026
Ovoca Bio EUR 1.3M 1.11M Dec/2025
Pharma Mar EUR 98.42M 9.2M Jun/2026
Prothena USD 11.66M 20.86M Jun/2026
PTC Therapeutics USD 771.07M 152.54M Jun/2026
Qiagen NV USD 581.45M 102.34M Jun/2026
Regeneron Pharmaceuticals USD 5.53B 422.9M Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sanofi EUR 31.93B 1.92B Jun/2026
Sarepta Therapeutics USD 502.91M 3.74M Jun/2026
Sartorius EUR 1.55B 102.8M Sep/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Tectonic Therapeutic USD 12.96M 3.29M Mar/2026
Tilray USD 259.32M 8.32M Sep/2025
Vanda Pharmaceuticals USD 145.16M 27.29M Dec/2025
Zealand Pharma A/S 404M 260.96M Mar/2026
Zz Pientze Pharmaceu CNY 3.02B 742.54M Jun/2026